Cardiac resynchronization therapy beyond nominal settings: Who needs individual programming of the atrioventricular and interventricular delay?

Europace

Volumn 14, Issue 12, 2012, Pages 1746-1753

  Bogaard, Margot D ^a   Meine, Mathias ^a   Tuinenburg, Anton E ^a   Maskara, Barun ^b   Loh, Peter ^a   Doevendans, Pieter A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Atrioventricular delay; Cardiac resynchronization therapy; dP dtmax; Heart failure; Interventricular delay

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; SPIRONOLACTONE;

ADULT; ARTICLE; ATRIOVENTRICULAR AND INTERVENTRICULAR DELAY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR PROCEDURE; CLINICAL ARTICLE; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; DRUG USE; FEMALE; GENDER; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PRESSURE; HEMODYNAMICS; HUMAN; ISCHEMIA; MALE; PR INTERVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QRS COMPLEX;

CARDIAC RESYNCHRONIZATION THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84867394360     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus170     Document Type: Article

References (22)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53. (Pubitemid 34603028)
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
3. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80. (Pubitemid 32224395)
4. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
5. Gras D, Gupta MS, Boulogne E, Guzzo L, Abraham WT. Optimization of AV and VV delays in the real-world CRT patient population: an international survey on current clinical practice. Pacing Clin Electrophysiol 2009;32(Suppl. 1): S236-9.
6. Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm 2004;1:562-7. (Pubitemid 39462715)
7. Ellenbogen KA, Gold MR, Meyer TE, Lozano IF, Mittal S, Waggoner AD et al. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiographyguided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation 2010;122:2660-8.
8. Boriani G, Muller CP, Seidl KH, Grove R, Vogt J, Danschel W et al. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study. Am Heart J 2006;151:1050-8.
9. Rao RK, Kumar UN, Schafer J, Viloria E, De Lurgio D, Foster E. Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: a randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation 2007;115:2136-44. (Pubitemid 46659065)
10. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999;99:2993-3001. (Pubitemid 29270428)
11. Perego GB, Chianca R, Facchini M, Frattola A, Balla E, Zucchi S et al. Simultaneous vs. sequential biventricular pacing in dilated cardiomyopathy: an acute hemodynamic study. Eur J Heart Fail 2003;5:305-13. (Pubitemid 37011859)
12. van Gelder BM, Bracke FA, Meijer A, Lakerveld LJM, Pijls NHJ. Effect of optimizing the VV interval on left ventricular contractility in cardiac resynchronization therapy. Am J Cardiol 2004;93:1500-3. (Pubitemid 38749206)
13. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol 1999;83: 130D-5D. (Pubitemid 29125694)
14. Butter C, Auricchio A, Stellbrink C, Fleck E, Ding J, Yu Y et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001;104:3026-9. (Pubitemid 34014051)
15. Gold MR, Niazi I, Giudici M, Leman RB, Sturdivant JL, Kim MH et al. A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2007;18: 490-6. (Pubitemid 46650333)
16. Mason DT. Usefulness and limitations of the rate of rise of intraventricular pressure (dp-dt) in the evaluation of myocardial contractility in man. Am J Cardiol 1969; 23:516-27.
17. Burri H, Sunthorn H, Somsen A, Zaza S, Fleury E, Shah D et al. Optimizing sequential biventricular pacing using radionuclide ventriculography. Heart Rhythm 2005;2:960-5. (Pubitemid 41372284)
18. Leon AR, Abraham WT, Brozena S, Daubert JP, Fisher WG, Gurley JC et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. J Am Coll Cardiol 2005;46:2298-304. (Pubitemid 41785501)
19. Bogaard MD, Doevendans PA, Leenders GE, Loh P, Hauer RN, van Wessel H et al. Can optimization of pacing settings compensate for a non-optimal left ventricular pacing site? Europace 2010;12:1262-9.
20. Pabari PA, Willson K, Stegemann B, van Geldorp I, Kyriacou A, Moraldo M et al. When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it. Heart Fail Rev 2010;16: 277-90.
21. Mullens W, Verga T, Grimm RA, Starling RC, Wilkoff BL, Tang WH. Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failure. J Am Coll Cardiol 2009;53: 600-7.
22. Bogaard MD, Houthuizen P, Bracke FA, Doevendans PA, Prinzen FW, Meine M et al. Baseline left ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in patients with cardiac resynchronization therapy. Eur J Heart Fail 2011;13:1126-32.